Disease Outcomes iN Older adults under extreme Heat, AiR pollution and Medication use (DO-NO-HARM)
极端高温、空气污染和药物使用下的老年人的疾病结果(DO-NO-HARM)
基本信息
- 批准号:10158389
- 负责人:
- 金额:$ 52.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-15 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Renal Failure with Renal Papillary NecrosisAddressAdrenergic beta-AntagonistsAdultAdverse drug eventAgingAirAir PollutantsAir PollutionAlternative TherapiesAntipsychotic AgentsArrhythmiaBiologicalBiometryCardiovascular systemCessation of lifeChronic DiseaseClimateClimatologyClinicalDataData ScienceDiseaseDisease OutcomeDrug PrescriptionsEarthquakesElderlyEmergency department visitEventExposure toFloodsFrequenciesHealthHealthcareHeart failureHeat Stress DisordersHeat WavesHemorrhageHospitalizationIndividualInstructionLeadLinkMedicareMorbidity - disease rateMucous MembraneOpioidOutcomeOverdoseOzoneParticulate MatterPatientsPharmaceutical PreparationsPharmacoepidemiologyPlayPoliciesPopulationResearchRhabdomyolysisRisk FactorsSafetySamplingSpecific qualifier valueStatistical MethodsSumTaiwanTemperatureTornadoesUrbanizationVenousWorkambient air pollutionclimate changecohortdesigndisabilitydosageextreme heathigh riskimprovedindividual patientlow socioeconomic statusmodifiable riskmortalitymortality riskmultiple chronic conditionsolder patientstudy populationsynergismtropospheric ozone
项目摘要
PROJECT SUMMARY/ABSTRACT
The frequency and duration of heat waves have increased significantly over the last 50 years. Heat waves kill
more people in a typical year than floods, tornadoes, and earthquakes combined and lead to excess
emergency room visits and hospitalizations. In addition, heat increases the frequency of days with unhealthy
levels of ground-level ozone and other harmful air pollutants. Air pollution caused three million deaths in 2012
globally and is causally linked to thromboembolic events, heart failure, and mucosal bleeding. The health
impacts of extreme heat and air pollution will only intensify as a result of the changing climate, urbanization,
and aging of the population. Older adults with chronic diseases, disabilities, and low socioeconomic status are
vulnerable to the health effects of extreme heat and air pollution, not only due to particular sensitivities and/or
low adaptive capacity, but also because of the multiple medications they often take. Although older adults
make up only 13% of the population, they account for more than one-third of medication use in the US.
However, the current evidence assessing health outcomes in relation to heat and air pollution lacks
consideration of this critically important and modifiable risk factor and its interactions with heat and air pollution.
Medication use is likely to play a key role in confounding the health effects of heat and air pollution and/or
further increasing morbidity and mortality in older adults through its synergy with heat and/or air pollution. An
interdisciplinary team of experts in climatology, biostatistics, data science, and pharmacoepidemiology will
work closely to design the studies and analyze linked climate and health care data. Our study addresses the
following specific aims: (1) assess the synergistic effect of extreme heat among users and non-users of
commonly used medications in high-risk older adults; (2) assess the synergistic effect of air pollution, i.e.,
particulate matter (PM) and ozone, among users and non-users of medications known to cause cardiovascular,
thromboembolic, and bleeding events in high-risk older adults; and (3) assess the synergistic effects of
extreme heat and air pollution among users and non-users of the aforementioned medications. The study
population will include older adults in the US and Taiwan for the period 2007-2016 who are at high risk for
heat- and air pollution-related morbidity and mortality and adverse drug events due to their multimorbidity. The
proposed study will not only quantify true casualties of extreme heat and air pollution in older adults, but also
the modifiable individual-level factors that put this population at higher risk. The results of this study will
redefine the safety of commonly used medications under conditions of extreme heat and air pollution. By
assessing the interactions between extreme heat, air pollution, and medication in vulnerable old adults, the
proposed study will produce rigorous and actionable evidence that will have a direct and long-lasting impact on
clinical decisions and regulatory policies while improving understanding of underlying biological mechanisms.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Soko Setoguchi-Iwata其他文献
Soko Setoguchi-Iwata的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Soko Setoguchi-Iwata', 18)}}的其他基金
Rutgers-NYU Center for Asian Health Promotion and Equity
罗格斯-纽约大学亚洲健康促进和公平中心
- 批准号:
10494154 - 财政年份:2021
- 资助金额:
$ 52.93万 - 项目类别:
Disease Outcomes iN Older adults under extreme Heat, AiR pollution and Medication use (DO-NO-HARM)
极端高温、空气污染和药物使用下的老年人的疾病结果(DO-NO-HARM)
- 批准号:
10400069 - 财政年份:2019
- 资助金额:
$ 52.93万 - 项目类别:
Improving Methods for Comparative Effectiveness Research in Cardiovascular Care
改进心血管护理比较有效性研究的方法
- 批准号:
7570767 - 财政年份:2008
- 资助金额:
$ 52.93万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 52.93万 - 项目类别:
Research Grant














{{item.name}}会员




